Home › Companies › TG THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and TG THERAPEUTICS INC.’s Form 8-K, filed 2025-06-13 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore TG THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are TG THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-13 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Michael S. Weiss | 75,488,727 | -- | -- | 12,748,318 | 30,193,346 | Majority: yes |
| Elect Director: Laurence N. Charney | 71,087,304 | -- | -- | 17,149,741 | 30,193,346 | Majority: yes |
| Elect Director: Yann Echelard | 51,734,184 | -- | -- | 36,502,861 | 30,193,346 | Majority: yes |
| Elect Director: Kenneth Hoberman | 53,398,586 | -- | -- | 34,838,459 | 30,193,346 | Majority: yes |
| Elect Director: Daniel Hume | 51,965,829 | -- | -- | 36,271,216 | 30,193,346 | Majority: yes |
| Elect Director: Sagar Lonial, MD | 47,757,163 | -- | -- | 40,479,882 | 30,193,346 | Majority: yes |
| Proposal 2 The vote with respect to the ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was as follows: | 117,836,086 | 442,199 | 152,106 | -- | -- | Majority: yes |
| Proposal 3 The advisory vote to approve the compensation of the Company's named executive officers was as follows: | 47,864,737 | 39,988,402 | 383,906 | -- | 30,193,346 | Majority: yes |
Source: TG THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-06-13 — read the filing on EDGAR.
Each item below shows how the 344 asset managers that disclosed a TG THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of TG THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2025-06-12.
Combines 7 wordings of this item as funds reported it.
54.5% Majority: yes · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Proposal 3 The advisory vote to approve the compensation of the Company's named executive officers was as follows:”): 47,864,737 for, 39,988,402 against, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,168,688 outstanding shares: 30% for, 25% against (56% of the company cast a for/against vote).
The 337 asset managers below cast 40% of the shares they voted on this item FOR (30,246,106 for, 46,122,914 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 15,811,636 | 920,038 | 1 | 0 | For |
| BlackRock | 923,835 | 10,894,599 | 0 | 0 | Against |
| State Street | 5,971,231 | 19,836 | 0 | 0 | For |
| Fidelity | 2,605,092 | 2,594,433 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 2,791,787 | 0 | 0 | Against |
| Soleus Capital Management, L.P. | 2,574,438 | 0 | 0 | 0 | For |
| Clearbridge Investments, LLC | 0 | 2,555,586 | 0 | 0 | Against |
| Charles Schwab | 0 | 2,428,086 | 0 | 0 | Against |
| PICTET ASSET MANAGEMENT SA | 0 | 1,730,211 | 0 | 0 | Against |
| Legg Mason | 0 | 1,423,151 | 0 | 0 | Against |
| Hood River Capital Management LLC | 0 | 1,371,508 | 0 | 0 | Against |
| Invesco | 0 | 1,139,514 | 0 | 0 | Against |
| Northern Trust | 0 | 1,021,768 | 0 | 0 | Against |
| Wellington | 0 | 936,408 | 0 | 0 | Against |
| Manager Directed Portfolios | 0 | 850,982 | 0 | 0 | Against |
| PRINCIPAL GLOBAL INVESTORS | 0 | 846,021 | 0 | 0 | Against |
| MUTUAL FUND SERIES TRUST | 0 | 718,814 | 0 | 0 | Against |
| T. Rowe Price | 0 | 668,927 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 0 | 664,899 | 0 | 0 | Against |
| Opaleye Management Inc. | 535,000 | 0 | 0 | 0 | For |
| Voya | 0 | 530,617 | 0 | 0 | Against |
| BANK OF MONTREAL /CAN/ | 0 | 503,846 | 0 | 0 | Against |
| LORD, ABBETT & CO. LLC | 0 | 497,746 | 0 | 0 | Against |
| BRAUN STACEY ASSOCIATES INC | 0 | 462,535 | 0 | 0 | Against |
| Lord Abbett | 0 | 428,862 | 0 | 0 | Against |
Showing the 25 largest of 337 asset managers. See all 337 in the interactive database.
Meeting held 2025-06-12.
Combines 2 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Proposal 2 The vote with respect to the ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was as follows:”): 117,836,086 for, 442,199 against, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,168,688 outstanding shares: 75% for, 0.3% against (75% of the company cast a for/against vote).
The 89 asset managers below cast 99.7% of the shares they voted on this item FOR (40,648,962 for, 105,144 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,252,554 | 1 | 0 | 0 | For |
| BlackRock | 7,948,974 | 0 | 0 | 0 | For |
| Fidelity | 3,895,192 | 0 | 0 | 0 | For |
| State Street | 2,211,325 | 0 | 0 | 0 | For |
| Legg Mason | 1,423,151 | 0 | 0 | 0 | For |
| Charles Schwab | 1,151,892 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 850,982 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Invesco | 444,233 | 0 | 0 | 0 | For |
| Lord Abbett | 428,862 | 0 | 0 | 0 | For |
| Equitable | 422,480 | 0 | 0 | 0 | For |
| Jackson National | 338,365 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 285,826 | 0 | 0 | 0 | For |
| TIAA | 267,839 | 0 | 0 | 0 | For |
| Goldman Sachs | 258,676 | 0 | 0 | 0 | For |
| T. Rowe Price | 255,946 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 237,934 | 0 | 0 | 0 | For |
| Voya | 229,767 | 0 | 0 | 0 | For |
| First Trust | 196,832 | 0 | 0 | 0 | For |
| Northwestern Mutual | 174,181 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 162,578 | 0 | 0 | 0 | For |
| Lincoln Financial | 159,074 | 0 | 0 | 0 | For |
| Hartford | 150,709 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 132,282 | 0 | 0 | 0 | For |
| Principal | 129,934 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.
Meeting held 2025-06-12.
Combines 2 wordings of this item as funds reported it.
99.6% fund support · no official result
The 87 asset managers below cast 99.6% of the shares they voted on this item FOR (40,483,997 for, 154,170 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,252,540 | 14 | 1 | 0 | For |
| BlackRock | 7,948,974 | 0 | 0 | 0 | For |
| Fidelity | 3,895,192 | 0 | 0 | 0 | For |
| State Street | 2,211,193 | 132 | 0 | 0 | For |
| Legg Mason | 1,423,151 | 0 | 0 | 0 | For |
| Charles Schwab | 1,151,892 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 850,982 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Invesco | 444,233 | 0 | 0 | 0 | For |
| Lord Abbett | 428,862 | 0 | 0 | 0 | For |
| Equitable | 422,480 | 0 | 0 | 0 | For |
| Jackson National | 338,365 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 285,826 | 0 | 0 | 0 | For |
| TIAA | 267,839 | 0 | 0 | 0 | For |
| Goldman Sachs | 258,676 | 0 | 0 | 0 | For |
| T. Rowe Price | 255,946 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 237,934 | 0 | 0 | 0 | For |
| Voya | 229,767 | 0 | 0 | 0 | For |
| First Trust | 196,832 | 0 | 0 | 0 | For |
| Northwestern Mutual | 174,181 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 162,578 | 0 | 0 | 0 | For |
| Lincoln Financial | 159,074 | 0 | 0 | 0 | For |
| Hartford | 150,709 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 132,282 | 0 | 0 | 0 | For |
| Principal | 129,934 | 0 | 0 | 0 | For |
Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.
Meeting held 2025-06-12.
Combines 6 wordings of this item as funds reported it.
81% Majority: yes · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Laurence N. Charney”): 71,087,304 for, 17,149,741 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,168,688 outstanding shares: 45% for, 11% withheld (56% of the company cast a for/withheld vote).
The 85 asset managers below cast 100% of the shares they voted on this item FOR (34,782,826 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,230,988 | 0 | 21,567 | 0 | For |
| BlackRock | 7,948,974 | 0 | 0 | 0 | For |
| Fidelity | 3,879,692 | 0 | 15,500 | 0 | For |
| State Street | 2,208,631 | 0 | 2,694 | 0 | For |
| Legg Mason | 1,409,100 | 0 | 14,051 | 0 | For |
| Charles Schwab | 0 | 0 | 1,151,892 | 0 | Abstain |
| Manager Directed Portfolios | 850,982 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 0 | 0 | 718,814 | 0 | Abstain |
| Invesco | 444,233 | 0 | 0 | 0 | For |
| Lord Abbett | 0 | 0 | 428,862 | 0 | Abstain |
| Equitable | 262,670 | 0 | 159,810 | 0 | For |
| Jackson National | 0 | 0 | 338,365 | 0 | Abstain |
| Columbia Threadneedle | 285,826 | 0 | 0 | 0 | For |
| TIAA | 267,839 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 258,676 | 0 | Abstain |
| T. Rowe Price | 0 | 0 | 255,946 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 237,934 | 0 | 0 | 0 | For |
| Voya | 229,767 | 0 | 0 | 0 | For |
| First Trust | 0 | 0 | 196,832 | 0 | Abstain |
| Northwestern Mutual | 0 | 0 | 174,181 | 0 | Abstain |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 162,578 | 0 | Abstain |
| Lincoln Financial | 102,800 | 0 | 56,274 | 0 | For |
| Hartford | 0 | 0 | 150,709 | 0 | Abstain |
| Principal Exchange-Traded Funds | 0 | 0 | 132,282 | 0 | Abstain |
| Principal | 0 | 0 | 129,934 | 0 | Abstain |
Showing the 25 largest of 85 asset managers. See all 85 in the interactive database.
Meeting held 2025-06-12.
Combines 6 wordings of this item as funds reported it.
59% Majority: yes · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Daniel Hume”): 51,965,829 for, 36,271,216 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,168,688 outstanding shares: 33% for, 23% withheld (56% of the company cast a for/withheld vote).
The 84 asset managers below cast 100% of the shares they voted on this item FOR (19,883,996 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 15,341,473 | 0 | 911,082 | 0 | For |
| BlackRock | 0 | 0 | 7,948,974 | 0 | Abstain |
| Fidelity | 2,513,502 | 0 | 1,381,690 | 0 | For |
| State Street | 5,338 | 0 | 2,205,987 | 0 | Abstain |
| Legg Mason | 0 | 0 | 1,423,151 | 0 | Abstain |
| Charles Schwab | 0 | 0 | 1,151,892 | 0 | Abstain |
| Manager Directed Portfolios | 850,982 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 0 | 0 | 718,814 | 0 | Abstain |
| Invesco | 444,233 | 0 | 0 | 0 | For |
| Lord Abbett | 0 | 0 | 428,862 | 0 | Abstain |
| Equitable | 0 | 0 | 422,480 | 0 | Abstain |
| Jackson National | 0 | 0 | 338,365 | 0 | Abstain |
| Columbia Threadneedle | 285,826 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 267,839 | 0 | Abstain |
| Goldman Sachs | 0 | 0 | 258,676 | 0 | Abstain |
| T. Rowe Price | 0 | 0 | 255,946 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 237,934 | 0 | Abstain |
| Voya | 229,767 | 0 | 0 | 0 | For |
| First Trust | 0 | 0 | 196,832 | 0 | Abstain |
| Northwestern Mutual | 46,100 | 0 | 128,081 | 0 | Abstain |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 162,578 | 0 | Abstain |
| Lincoln Financial | 0 | 0 | 159,074 | 0 | Abstain |
| Hartford | 0 | 0 | 150,709 | 0 | Abstain |
| Principal Exchange-Traded Funds | 0 | 0 | 132,282 | 0 | Abstain |
| Principal | 0 | 0 | 129,934 | 0 | Abstain |
Showing the 25 largest of 84 asset managers. See all 84 in the interactive database.
Meeting held 2025-06-12.
Combines 6 wordings of this item as funds reported it.
61% Majority: yes · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kenneth Hoberman”): 53,398,586 for, 34,838,459 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,168,688 outstanding shares: 34% for, 22% withheld (56% of the company cast a for/withheld vote).
The 84 asset managers below cast 100% of the shares they voted on this item FOR (22,508,158 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,230,974 | 0 | 21,581 | 0 | For |
| BlackRock | 0 | 0 | 7,948,974 | 0 | Abstain |
| Fidelity | 1,243,715 | 0 | 2,651,477 | 0 | Abstain |
| State Street | 2,208,631 | 0 | 2,694 | 0 | For |
| Legg Mason | 1,409,100 | 0 | 14,051 | 0 | For |
| Charles Schwab | 0 | 0 | 1,151,892 | 0 | Abstain |
| Manager Directed Portfolios | 850,982 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 0 | 0 | 718,814 | 0 | Abstain |
| Invesco | 0 | 0 | 444,233 | 0 | Abstain |
| Lord Abbett | 0 | 0 | 428,862 | 0 | Abstain |
| Equitable | 40,700 | 0 | 381,780 | 0 | Abstain |
| Jackson National | 0 | 0 | 338,365 | 0 | Abstain |
| Columbia Threadneedle | 0 | 0 | 285,826 | 0 | Abstain |
| TIAA | 267,839 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 258,676 | 0 | Abstain |
| T. Rowe Price | 0 | 0 | 255,946 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 237,934 | 0 | Abstain |
| Voya | 0 | 0 | 229,767 | 0 | Abstain |
| First Trust | 0 | 0 | 196,832 | 0 | Abstain |
| Northwestern Mutual | 0 | 0 | 174,181 | 0 | Abstain |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 162,578 | 0 | Abstain |
| Lincoln Financial | 102,800 | 0 | 56,274 | 0 | For |
| Hartford | 0 | 0 | 150,709 | 0 | Abstain |
| Principal Exchange-Traded Funds | 0 | 0 | 132,282 | 0 | Abstain |
| Principal | 0 | 0 | 129,934 | 0 | Abstain |
Showing the 25 largest of 84 asset managers. See all 84 in the interactive database.
Meeting held 2025-06-12.
Combines 6 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael S. Weiss”): 75,488,727 for, 12,748,318 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,168,688 outstanding shares: 47.7% for, 8% withheld (56% of the company cast a for/withheld vote).
The 84 asset managers below cast 100% of the shares they voted on this item FOR (36,317,507 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,238,524 | 0 | 14,031 | 0 | For |
| BlackRock | 7,948,974 | 0 | 0 | 0 | For |
| Fidelity | 3,879,692 | 0 | 15,500 | 0 | For |
| State Street | 2,208,631 | 0 | 2,694 | 0 | For |
| Legg Mason | 1,409,100 | 0 | 14,051 | 0 | For |
| Charles Schwab | 1,151,892 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 850,982 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 0 | 0 | 718,814 | 0 | Abstain |
| Invesco | 444,233 | 0 | 0 | 0 | For |
| Lord Abbett | 0 | 0 | 428,862 | 0 | Abstain |
| Equitable | 262,670 | 0 | 159,810 | 0 | For |
| Jackson National | 0 | 0 | 338,365 | 0 | Abstain |
| Columbia Threadneedle | 285,826 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 267,839 | 0 | Abstain |
| Goldman Sachs | 258,676 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 255,946 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 237,934 | 0 | 0 | 0 | For |
| Voya | 229,767 | 0 | 0 | 0 | For |
| First Trust | 0 | 0 | 196,832 | 0 | Abstain |
| Northwestern Mutual | 46,100 | 0 | 128,081 | 0 | Abstain |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 162,578 | 0 | Abstain |
| Lincoln Financial | 102,800 | 0 | 56,274 | 0 | For |
| Hartford | 0 | 0 | 150,709 | 0 | Abstain |
| Principal Exchange-Traded Funds | 0 | 0 | 132,282 | 0 | Abstain |
| Principal | 0 | 0 | 129,934 | 0 | Abstain |
Showing the 25 largest of 84 asset managers. See all 84 in the interactive database.
Meeting held 2025-06-12.
Combines 6 wordings of this item as funds reported it.
54.1% Majority: yes · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Sagar Lonial, MD”): 47,757,163 for, 40,479,882 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,168,688 outstanding shares: 30% for, 26% withheld (56% of the company cast a for/withheld vote).
The 84 asset managers below cast 100% of the shares they voted on this item FOR (16,904,224 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 15,341,462 | 0 | 911,093 | 0 | For |
| BlackRock | 0 | 0 | 7,948,974 | 0 | Abstain |
| Fidelity | 0 | 0 | 3,895,192 | 0 | Abstain |
| State Street | 5,338 | 0 | 2,205,987 | 0 | Abstain |
| Legg Mason | 0 | 0 | 1,423,151 | 0 | Abstain |
| Charles Schwab | 0 | 0 | 1,151,892 | 0 | Abstain |
| Manager Directed Portfolios | 850,982 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 0 | 0 | 718,814 | 0 | Abstain |
| Invesco | 444,233 | 0 | 0 | 0 | For |
| Lord Abbett | 0 | 0 | 428,862 | 0 | Abstain |
| Equitable | 0 | 0 | 422,480 | 0 | Abstain |
| Jackson National | 0 | 0 | 338,365 | 0 | Abstain |
| Columbia Threadneedle | 0 | 0 | 285,826 | 0 | Abstain |
| TIAA | 0 | 0 | 267,839 | 0 | Abstain |
| Goldman Sachs | 0 | 0 | 258,676 | 0 | Abstain |
| T. Rowe Price | 0 | 0 | 255,946 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 237,934 | 0 | Abstain |
| Voya | 0 | 0 | 229,767 | 0 | Abstain |
| First Trust | 0 | 0 | 196,832 | 0 | Abstain |
| Northwestern Mutual | 46,100 | 0 | 128,081 | 0 | Abstain |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 162,578 | 0 | Abstain |
| Lincoln Financial | 0 | 0 | 159,074 | 0 | Abstain |
| Hartford | 0 | 0 | 150,709 | 0 | Abstain |
| Principal Exchange-Traded Funds | 0 | 0 | 132,282 | 0 | Abstain |
| Principal | 0 | 0 | 129,934 | 0 | Abstain |
Showing the 25 largest of 84 asset managers. See all 84 in the interactive database.
Meeting held 2025-06-12.
Combines 6 wordings of this item as funds reported it.
59% Majority: yes · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Yann Echelard”): 51,734,184 for, 36,502,861 withheld, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,168,688 outstanding shares: 33% for, 23% withheld (56% of the company cast a for/withheld vote).
The 84 asset managers below cast 100% of the shares they voted on this item FOR (19,881,753 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 15,341,472 | 0 | 911,083 | 0 | For |
| BlackRock | 0 | 0 | 7,948,974 | 0 | Abstain |
| Fidelity | 2,513,502 | 0 | 1,381,690 | 0 | For |
| State Street | 5,338 | 0 | 2,205,987 | 0 | Abstain |
| Legg Mason | 0 | 0 | 1,423,151 | 0 | Abstain |
| Charles Schwab | 0 | 0 | 1,151,892 | 0 | Abstain |
| Manager Directed Portfolios | 850,982 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 0 | 0 | 718,814 | 0 | Abstain |
| Invesco | 444,233 | 0 | 0 | 0 | For |
| Lord Abbett | 0 | 0 | 428,862 | 0 | Abstain |
| Equitable | 0 | 0 | 422,480 | 0 | Abstain |
| Jackson National | 0 | 0 | 338,365 | 0 | Abstain |
| Columbia Threadneedle | 285,826 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 267,839 | 0 | Abstain |
| Goldman Sachs | 0 | 0 | 258,676 | 0 | Abstain |
| T. Rowe Price | 0 | 0 | 255,946 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 237,934 | 0 | Abstain |
| Voya | 229,767 | 0 | 0 | 0 | For |
| First Trust | 0 | 0 | 196,832 | 0 | Abstain |
| Northwestern Mutual | 46,100 | 0 | 128,081 | 0 | Abstain |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 162,578 | 0 | Abstain |
| Lincoln Financial | 0 | 0 | 159,074 | 0 | Abstain |
| Hartford | 0 | 0 | 150,709 | 0 | Abstain |
| Principal Exchange-Traded Funds | 0 | 0 | 132,282 | 0 | Abstain |
| Principal | 0 | 0 | 129,934 | 0 | Abstain |
Showing the 25 largest of 84 asset managers. See all 84 in the interactive database.
Meeting held 2025-06-12.
100% fund support · no official result
The 4 asset managers below cast 100% of the shares they voted on this item FOR (11,783 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Jackson Creek Investment Advisors LLC | 7,230 | 0 | 0 | 0 | For |
| Zacks Trust | 3,689 | 0 | 0 | 0 | For |
| BOSUN ASSET MANAGEMENT, LLC | 860 | 0 | 0 | 0 | For |
| SARATOGA ADVANTAGE TRUST | 4 | 0 | 0 | 0 | For |
Meeting held 2025-06-12.
96% fund support · no official result
The 3 asset managers below cast 96% of the shares they voted on this item FOR (111,461 for, 4,885 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 102,837 | 0 | 0 | 0 | For |
| VALUED ADVISERS TRUST | 8,624 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 4,885 | 0 | 0 | Against |
Meeting held 2025-06-12.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (32,750 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RBB Fund Trust | 21,520 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 11,230 | 0 | 0 | 0 | For |
Meeting held 2025-06-12.
All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RBB Fund Trust | 21,520 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 11,230 | 0 | 0 | 0 | For |
Meeting held 2025-06-12.
99.6% Majority: yes · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Proposal 2 The vote with respect to the ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was as follows:”): 117,836,086 for, 442,199 against, per its Form 8-K filed 2025-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,168,688 outstanding shares: 75% for, 0.3% against (75% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (32,750 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RBB Fund Trust | 21,520 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 11,230 | 0 | 0 | 0 | For |
Meeting held 2024-06-14 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
58% Majority: yes · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Proposal 3 The advisory vote to approve the compensation of the Company's named executive officers was as follows:”): 42,346,581 for, 31,019,084 against, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,168,688 outstanding shares: 27% for, 20% against (46.4% of the company cast a for/against vote).
The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 282 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| COLDSTREAM CAPITAL MANAGEMENT INC | 0 | 282 | 0 | 0 | Against |
| Echo45 Advisors LLC | 0 | 0 | 0 | 0 | -- |
Ranked by the number of TG THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 158,168,688 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 10.58% |
| 2 | BlackRock | 7.47% |
| 3 | State Street | 3.79% |
| 4 | Fidelity | 3.29% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 1.77% |
| 6 | Soleus Capital Management, L.P. | 1.63% |
| 7 | Clearbridge Investments, LLC | 1.62% |
| 8 | Charles Schwab | 1.54% |
| 9 | PICTET ASSET MANAGEMENT SA | 1.09% |
| 10 | Legg Mason | 0.90% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 13.59% | 13F |
| Vanguard Group | 9.87% | 13F |
| State Street | 4.70% | 13F |
| Geode Capital | 2.08% | 13F |
| Morgan Stanley | 1.30% | 13F |
| Goldman Sachs | 1.21% | 13F |
| Nuveen | 1.14% | 13F |
| FMR (Fidelity) | 1.10% | 13F |
| Citadel Advisors | 1.01% | 13F |
| Northern Trust | 0.97% | 13F |
Percentages above are of 158,168,688 shares outstanding, as reported by TG THERAPEUTICS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TG THERAPEUTICS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At TG THERAPEUTICS INC.'s shareholder meeting held 2025-06-12, in the 2024-2025 proxy season, 344 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,083 separate fund positions. Their filings are grouped here into 15 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — An advisory vote to approve the compensation of our named executive officers. — FOR was 54.5% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: TG THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-13.
TG THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.